Australia markets close in 6 hours 9 minutes

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6401-0.0379 (-5.59%)
At close: 04:00PM EDT
0.6449 +0.00 (+0.75%)
After hours: 07:14PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.17M
Enterprise value 3.91M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.00
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.44

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3-46.67%
S&P500 52-week change 320.07%
52-week high 31.7500
52-week low 30.2740
50-day moving average 30.7277
200-day moving average 30.5714

Share statistics

Avg vol (3-month) 35.41M
Avg vol (10-day) 3239.24k
Shares outstanding 517.45M
Implied shares outstanding 617.45M
Float 88.31M
% held by insiders 152.35%
% held by institutions 11.55%
Shares short (28 Mar 2024) 4170.5k
Short ratio (28 Mar 2024) 40.32
Short % of float (28 Mar 2024) 43.32%
Short % of shares outstanding (28 Mar 2024) 40.98%
Shares short (prior month 29 Feb 2024) 4848.8k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-53.66%
Return on equity (ttm)-107.19%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-8.4M
Diluted EPS (ttm)-0.6100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.27M
Total cash per share (mrq)0.42
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.17
Book value per share (mrq)0.38

Cash flow statement

Operating cash flow (ttm)-7.86M
Levered free cash flow (ttm)-5.01M